Inhibiting APOL1 to Treat Kidney Disease

被引：9
作者：
Williams, Winfred W.
Ingelfinger, Julie R.
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2023年 / 388卷 / 11期
关键词：
VARIANTS; MYH9;
D O I：
10.1056/NEJMe2208455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Variant APOL1, Inaxaplin, and FSGS This article describes the science behind a study on the use of inaxaplin in patients with focal segmental glomerulosclerosis who have two risk alleles of the gene APOL1. © 2023 Massachusetts Medical Society.
引用
收藏
页码：1045 / 1049
页数：5
相关论文
共 13 条
  • [1] Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice
    Beckerman, Pazit
    Bi-Karchin, Jing
    Park, Ae Seo Deok
    Qiu, Chengxiang
    Dummer, Patrick D.
    Soomro, Irfana
    Boustany-Kari, Carine M.
    Pullen, Steven S.
    Miner, Jeffrey H.
    Hu, Chien-An A.
    Rohacs, Tibor
    Inoue, Kazunori
    Ishibe, Shuta
    Saleem, Moin A.
    Palmer, Matthew B.
    Cuervo, Ana Maria
    Kopp, Jeffrey B.
    Susztak, Katalin
    [J]. NATURE MEDICINE, 2017, 23 (04) : 429 - +
  • [2] The evolving story of apolipoprotein L1 nephropathy: the end of the beginning
    Daneshpajouhnejad, Parnaz
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    Rosenberg, Avi Z.
    [J]. NATURE REVIEWS NEPHROLOGY, 2022, 18 (05) : 307 - 320
  • [3] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
    Egbuna, Ogo
    Zimmerman, Brandon
    Manos, George
    Fortier, Anne
    Chirieac, Madalina C.
    Dakin, Leslie A.
    Friedman, David J.
    Bramham, Kate
    Campbell, Kirk
    Knebelmann, Bertrand
    Barisoni, Laura
    Falk, Ronald J.
    Gipson, Debbie S.
    Lipkowitz, Michael S.
    Ojo, Akinlolu
    Bunnage, Mark E.
    Pollak, Martin R.
    Altshuler, David
    Chertow, Glenn M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (11) : 969 - 979
  • [4] APOL1 Nephropathy: From Genetics to Clinical Applications
    Friedman, David J.
    Pollak, Martin R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (02): : 294 - 303
  • [5] Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
    Genovese, Giulio
    Friedman, David J.
    Ross, Michael D.
    Lecordier, Laurence
    Uzureau, Pierrick
    Freedman, Barry I.
    Bowden, Donald W.
    Langefeld, Carl D.
    Oleksyk, Taras K.
    Knob, Andrea L. Uscinski
    Bernhardy, Andrea J.
    Hicks, Pamela J.
    Nelson, George W.
    Vanhollebeke, Benoit
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    Pays, Etienne
    Pollak, Martin R.
    [J]. SCIENCE, 2010, 329 (5993) : 841 - 845
  • [6] Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity
    Giovinazzo, Joseph A.
    Thomson, Russell P.
    Khalizova, Nailya
    Zager, Patrick J.
    Malani, Nirav
    Rodriguez-Boulan, Enrique
    Raper, Jayne
    Schreiner, Ryan
    [J]. ELIFE, 2020, 9
  • [7] MYH9 is associated with nondiabetic end-stage renal disease in African Americans
    Kao, W. H. Linda
    Klag, Michael J.
    Meoni, Lucy A.
    Reich, David
    Berthier-Schaad, Yvette
    Li, Man
    Coresh, Josef
    Patterson, Nick
    Tandon, Arti
    Powe, Neil R.
    Fink, Nancy E.
    Sadler, John H.
    Weir, Matthew R.
    Abboud, Hanna E.
    Adler, Sharon G.
    Divers, Jasmin
    Iyengar, Sudha K.
    Freedman, Barry I.
    Kimmel, Paul L.
    Knowler, William C.
    Kohn, Orly F.
    Kramp, Kristopher
    Leehey, David J.
    Nicholas, Susanne B.
    Pahl, Madeleine V.
    Schelling, Jeffrey R.
    Sedor, John R.
    Thornley-Brown, Denyse
    Winkler, Cheryl A.
    Smith, Michael W.
    Parekh, Rulan S.
    [J]. NATURE GENETICS, 2008, 40 (10) : 1185 - 1192
  • [8] MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
    Kopp, Jeffrey B.
    Smith, Michael W.
    Nelson, George W.
    Johnson, Randall C.
    Freedman, Barry I.
    Bowden, Donald W.
    Oleksyk, Taras
    McKenzie, Louise M.
    Kajiyama, Hiroshi
    Ahuja, Tejinder S.
    Berns, Jeffrey S.
    Briggs, William
    Cho, Monique E.
    Dart, Richard A.
    Kimmel, Paul L.
    Korbet, Stephen M.
    Michel, Donna M.
    Mokrzycki, Michele H.
    Schelling, Jeffrey R.
    Simon, Eric
    Trachtman, Howard
    Vlahov, David
    Winkler, Cheryl A.
    [J]. NATURE GENETICS, 2008, 40 (10) : 1175 - 1184
  • [9] Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
    McCarthy, Gizelle M.
    Blasio, Angelo
    Donovan, Olivia G.
    Schaller, Lena B.
    Bock-Hughes, Althea
    Magraner, Jose M.
    Suh, Jung Hee
    Tattersfield, Calum F.
    Stillman, Isaac E.
    Shah, Shrijal S.
    Zsengeller, Zsuzsanna K.
    Subramanian, Balajikarthick
    Friedman, David J.
    Pollak, Martin R.
    [J]. DISEASE MODELS & MECHANISMS, 2021, 14 (08)
  • [10] Worldwide Frequencies of APOL1 Renal Risk Variants
    Nadkarni, Girish N.
    Gignoux, Christopher R.
    Sorokin, Elena P.
    Daya, Michelle
    Rahman, Rayees
    Barnes, Kathleen C.
    Wassel, Christina L.
    Kenny, Eimear E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26) : 2571 - +
12